Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
60
Number of overlapping holdings
100.0%
% of XLV's 60 holdings also in VHT
15.5%
% of VHT's 415 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus VHT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XLV |
Weight in VHT |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 13.4% | 12.0% | 12.0% |
|
UNITEDHEALTH GROUP INC | 8.5% | 7.4% | 7.4% |
|
JOHNSON & JOHNSON | 7.7% | 5.0% | 5.0% |
|
ABBVIE INC | 6.2% | 4.9% | 4.9% |
|
ABBOTT LABORATORIES | 4.6% | 4.0% | 4.0% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to VHT
|
JOHNSON & JOHNSON | 2.7% |
|
ELI LILLY & CO | 1.4% |
|
ABBVIE INC | 1.3% |
|
UNITEDHEALTH GROUP INC | 1.1% |
|
MERCK & CO. INC. | 0.7% |
|
ABBOTT LABORATORIES | 0.6% |
|
INTUITIVE SURGICAL INC | 0.4% |
|
THERMO FISHER SCIENTIFIC INC | 0.4% |
|
AMGEN INC | 0.4% |
|
BOSTON SCIENTIFIC CORP | 0.4% |
XLV Underweight Relative to VHT
|
VEEVA SYSTEMS INC-CLASS A | -0.6% |
|
ALNYLAM PHARMACEUTICALS INC | -0.5% |
|
NATERA INC | -0.3% |
|
INTRA-CELLULAR THERAPIES INC | -0.2% |
|
ROYALTY PHARMA PLC CLASS A | -0.2% |
|
INSMED INC | -0.2% |
|
UNITED THERAPEUTICS CORP | -0.2% |
|
TENET HEALTHCARE CORP | -0.2% |
|
ILLUMINA INC | -0.2% |
|
BIOMARIN PHARMACEUTICAL INC | -0.2% |